Physician
Cardiology
Dr. Vivek Rajagopal, MD
|
|
Give Review
Vivek Rajagopal is an expert in the field of Cardiology. He researched medicine at University of Michigan Medical School. He received awards:"Atlanta Magazine: Top Doctors" and "CMS Meaningful Use Stage 1 Certification". Vivek Rajagopal is a published doctor and has 29 publications published. The lastest was: 'Methotrexate-associated lymphoproliferative disorder presenting as disseminated malignancy.' Vivek Rajagopal accepts Medicare payments and is listed with Medicare.gov.
Publications
- Emerging transcatheter therapies for Aortic and mitral disease.
- Advances in the percutaneous treatment of Aortic and mitral valve disease.
- Factor Xa inhibitors in Acute coronary syndromes: moving from mythology to reality.
- Methotrexate-associated lymphoproliferative disorder presenting as disseminated malignancy.
- An uncommon cause of pyrexia of unknown origin.
- A novel percutaneous mechanical biventricular bridge to recovery in severe cardiac allograft rejection.
- Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation Myocardial infarction.
- Carotid stenting: the preferred management for Carotid atherosclerosis?
- The optimal treatment of Carotid atherosclerosis: a 2008 update and literature review.
- Predictors of difficult carotid stenting as determined by Aortic arch angiography.
- The safety of a bivalirudin-based approach in patients undergoing rotational atherectomy.
- Inflammation: implications for understanding the Heart-brain connection.
- Management of carotid artery Disease in the high-risk patient with emphasis on the SAPPHIRE study.
- Impact of diabetes mellitus on outcome of patients undergoing Carotid artery stenting: insights from a single center registry.
- Controversies of oral antiplatelet therapy in Acute coronary syndromes and percutaneous coronary intervention.
- Relation of an elevated white blood cell count after percutaneous Coronary intervention to long-term mortality.
- Coronary restenosis: a review of mechanisms and management.
- Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous Coronary intervention and clinical outcomes.
- Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous Coronary intervention with a sirolimus-eluting stent.
- Incidence of Atrial fibrillation in heart transplant patients: long-term follow-up.
- Outcomes of patients with Acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluati...
- Gaps in Myocardial infarction care: how might we best EFFECT change?
- Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers.
- Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous Coronary intervention.
- Acute coronary syndrome statistics: what you don''t see can hurt you.
- Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent Coronary art...
- Relation of myocardial perfusion to mortality after primary percutaneous Coronary intervention.
- Effectiveness and safety of bivalirudin during percutaneous Coronary intervention in a single medical center.
Schools
University Of Michigan Medical School
UCLA Medical Center
Stanford Hospital
Cleveland Clinic
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Atlanta Magazine: Top Doctors
- CMS Meaningful Use Stage 1 Certification
Education
-
Cleveland Clinic Foundation -
Stanford University -
University of Washington -
UCLA Medical Center -
University of Michigan Medical School
Hospital
-
Piedmont Hospital
Drug Facts
| NPI NUMBER | 1598988149 | |
| NPPES Provider LastName | RAJAGOPAL | |
| NPPES Provider FirstName | VIVEK | |
| NPPES Provider ZIPCode | 303091704 | |
| NPPES Provider State | GA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 820.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598988149 |
| Last Name Of The Provider | RAJAGOPAL |
| First Name Of The Provider | VIVEK |
| View All |
Similar Doctors
|
|
Dr. Dan Sorescu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert D. Hoff, MD |
|
|
Dr. Jack P. Chen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Joseph I. Miller III, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nicholas J. Lembo, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Henry Liberman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Philip A. Romm, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adefisayo Oduwole, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin D. Demoss, MD |
|
|
Dr. Muhammad Hawasli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel Harris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raphael S. Levine, MD |
|
|
Dr. Charles L. Brown Jr., MD |
|
|
Dr. Robert G. Dillon, MD |
|
|
Dr. Mazen Khalil, MD |
|
|
Dedra I. Blalock |
|
|
Susan J. Clymer, NP |
|
|
James A. Grantham |
|
|
Achilles A. Zacharoulis
This Doctor is OpenDoctor Recommended.
|
|
|
Robert Wilson
This Doctor is OpenDoctor Recommended.
|